Document Detail

Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial.
MedLine Citation:
PMID:  21422084     Owner:  NLM     Status:  Publisher    
Background: Despite limited data, international guidelines recommend the use of intravenous immunoglobulin (IVIg) in neonates with rhesus hemolytic disease. Objective: We tested whether prophylactic use of IVIg reduces the need for exchange transfusions in neonates with rhesus hemolytic disease. Design and Setting: We performed a randomized, double-blind, placebo-controlled trial in neonates with rhesus hemolytic disease. After stratification for treatment with intrauterine transfusion, neonates were randomly assigned for IVIg (0.75 g/kg) or placebo (5% glucose). The primary outcome was the rate of exchange transfusions. Secondary outcomes were duration of phototherapy, maximum bilirubin levels, and the need of top-up red-cell transfusions. Results: Eighty infants were included in the study, 53 of whom (66%) were treated with intrauterine transfusion(s). There was no difference in the rate of exchange transfusions between the IVIg and placebo groups (7 of 41 [17%] vs 6 of 39 [15%]; P = .99) and in the number of exchange transfusions per patient (median [range]: 0 [0-2] vs 0 [0-2]; P = .90) or in duration of phototherapy (4.7 [1.8] vs 5.1 [2.1] days; P = .34), maximum bilirubin levels (14.8 [4.7] vs 14.1 [4.9] mg/dL; P = .52), and proportion of neonates who required top-up red-cell transfusions (34 of 41 [83%] vs 34 of 39 [87%]; P = .76). Conclusions: Prophylactic IVIg does not reduce the need for exchange transfusion or the rates of other adverse neonatal outcomes. Our findings do not support the use of IVIg in neonates with rhesus hemolytic disease.
Vivianne E H J Smits-Wintjens; Frans J Walther; Mirjam E A Rath; Irene T M Lindenburg; Arjan B Te Pas; Christine M Kramer; Dick Oepkes; Anneke Brand; Enrico Lopriore
Related Documents :
9277604 - Birth weight and cognitive function in young adult life: historical cohort study.
19865074 - Maternal exposure to perfluorinated acids and fetal growth.
581604 - Very low birthweight infants: a follow-up study.
24904504 - The emergence of use of a rake-like tool: a longitudinal study in human infants.
455784 - Anaphylactic sensitivity of guinea-pigs drinking different preparations of cows' milk a...
19424054 - No relation between in-utero exposure to haart and intrauterine growth retardation.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-21
Journal Detail:
Title:  Pediatrics     Volume:  -     ISSN:  1098-4275     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Neonatology, Department of Pediatrics.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk Factors for Hand, Foot, and Mouth Disease and Herpangina and the Preventive Effect of Hand-wash...
Next Document:  Medically underserved girls receive less evaluation for short stature.